Springer and Breast Cancer Research Foundation to Collaborate on Book Series
New York / Heidelberg, 13 August 2012—Springer will publish a series of books in cooperation with The Breast Cancer Research Foundation (BCRF) starting in 2013. Four books will be published annually, and will be included in the Springer series Advances in Experimental Medicine and Biology. The scope and focus of the volumes will encompass important cohesive themes in the area of breast cancer research, with the aim to conceptually advance the field.
BCRF was founded in 1993 by the late Evelyn Lauder and has funded several major breakthroughs in breast cancer. BCRF will hold editorial responsibility for the books and Springer will handle production, marketing, sales and distribution. The books will be available as eBooks on Springer’s online platform www.springerlink.com and in print-to-order (PTO) format.
Spearheading the editorial development of these books are Larry Norton, MD, BCRF Scientific Director, and Deputy Physician-in-Chief for Breast Cancer Programs and Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan-Kettering Cancer Center, and Clifford Hudis, MD, Chairman of the BCRF Scientific Advisory Committee and Chief of Breast Cancer Medicine Service at Memorial Sloan-Kettering.
Dr. Norton said, "The extraordinary collection of breast cancer experts represented by BCRF grantees reflects the multidimensional nature of the problem and our approaches toward solving it. We expect that this book series will capture not only the state of current research but also the creative thinking intrinsic to the process, providing guidance for other investigators as well as information for all concerned individuals."
Andrea Macaluso, Editorial Director Biomedicine at Springer said, “We are delighted that the Breast Cancer Research Foundation has named Springer as their publishing partner. BCRF has successfully raised visibility on the importance of scientific research and their grantees are world renowned researchers and clinicians. We could not be more thrilled to work with them to strategically develop scientific publications highlighting their remarkable work in breast cancer research.”